⌘K

Login Start Free

Home/Filings/4/0001209191-15-019229

4//SEC Filing

BELLICUM PHARMACEUTICALS, INC 4

Accession 0001209191-15-019229

CIK 0001358403operating

View on SEC.gov Company Profile

Filed

Feb 25, 7:00 PM ET

Accepted

Feb 26, 6:31 PM ET

Size

5.6 KB

Accession

0001209191-15-019229

Insider Transaction Report

Form 4

Period: 2015-02-24

BELLICUM PHARMACEUTICALS, INCBLCM

Sr. VP of Bus. Development

Transactions

Award
Stock Option (right to buy)
2015-02-24+60,000→ 60,000 total
Exercise: $23.47Exp: 2025-02-23→ Common Stock (60,000 underlying)

Footnotes (1)

[F1]25% of the shares subject to the stock option vest and become exercisable on February 24, 2016, and the remaining shares subject to the stock option vest and become exercisable in 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

BELLICUM PHARMACEUTICALS, INC

CIK 0001358403

Entity typeoperating

Related Parties

1

filerCIK 0001358403

Filing Metadata

Form type: 4
Filed: Feb 25, 7:00 PM ET
Accepted: Feb 26, 6:31 PM ET
Size: 5.6 KB

View on SEC.gov